menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Fagron publishes its annual report 2024

    GLOBENEWSWIRE

    Enforcement Report - Week of February 26, 2025

    FDA

    Fagron Posts 14% Revenue Growth & 17% REBITDA Increase For FY 2024

    GLOBENEWSWIRE

    Fagron solidifies leadership position with acquisition of Guinama

    GLOBENEWSWIRE

    Fagron Expands With CareFirst And Injeplast Acquisitions

    GLOBENEWSWIRE

    Fagron Provides FDA Update on Wichita Inspection

    GLOBENEWSWIRE

    Disclosure of notification received from FMR LLC

    GLOBENEWSWIRE

    Angels for Change Provides Project PROTECT Grant Update

    PR NEWSWIRE

    Fagron Reports Outstanding Q3 2024 With 12.1% Revenue Growth

    GLOBENEWSWIRE

    Solera Health Unveils New Brand Identity

    GLOBENEWSWIRE

    Fagron’s share buy-back program: Weekly update

    GLOBENEWSWIRE

    Fagron’s share buy-back program: Weekly update

    GLOBENEWSWIRE

    Fagron Reports Strong H1 2024 Performance

    GLOBENEWSWIRE

    Fagron shareholders approve all voting items at AGM and EGM

    GLOBENEWSWIRE

    Disclosure notification from Mawer Investment Management Ltd.

    GLOBENEWSWIRE

    Fagron publishes annual report 2023

    GLOBENEWSWIRE

    Fagron delivers strong performance with 12% topline growth

    GLOBENEWSWIRE

    Disclosure notification from AOC Pharma S.Ã r.l. passing 10% threshold

    GLOBENEWSWIRE

    Enforcement Report - Week of December 27, 2023

    FDA

    Disclosure of notification received from BNP Paribas Asset Management SA

    GLOBENEWSWIRE

    Continued strong Q3 performance with 11% topline growth to ‚¬191 million

    GLOBENEWSWIRE

    Fagron completes share buy-back program

    GLOBENEWSWIRE

    Progress share buy-back program Fagron

    GLOBENEWSWIRE

    Progress share buy-back program Fagron

    GLOBENEWSWIRE

    Progress share buy-back program Fagron

    GLOBENEWSWIRE

    Progress share buy-back program Fagron

    GLOBENEWSWIRE

    Progress share buy-back program Fagron

    GLOBENEWSWIRE

    Fagron delivers strong performance with 13% growth and 14% increase in REBITDA

    GLOBENEWSWIRE

    Fagron delivers strong performance with 13% growth & 14% increase in REBITDA

    GLOBENEWSWIRE

    Fagron shareholders approve majority voting items

    GLOBENEWSWIRE

    Strong first quarter performance with 16% topline growth to €181 million

    GLOBENEWSWIRE

    Fagron publishes agenda for annual shareholders meeting

    GLOBENEWSWIRE

    Fagron publishes annual report 2022

    GLOBENEWSWIRE

    Fagron reports 19% topline growth, 11% increase in REBITDA

    GLOBENEWSWIRE

    Disclosure of notifications received from Active Ownership Corporation S.Ã r.l.

    GLOBENEWSWIRE

    Fagron delivers topline growth of 21.5% to €173 million

    GLOBENEWSWIRE

    Fagron commits to set science-based emission reduction targets

    GLOBENEWSWIRE

    Fagron expands its US sterile compounding footprint with East coast acquisition

    GLOBENEWSWIRE

    Fagron Group B.V. Receives FDA Warning Letter

    FDA

    Fagron increases share capital through exercise subscription rights

    GLOBENEWSWIRE

    Enforcement Report - Week of May 18, 2022

    FDA

    Fagron Sterile Services US Launches RFID enabled products

    PRNEWSWIRE

    Fagron shareholders approve all voting items AGM and EGM

    GLOBENEWSWIRE

    Fagron Inc. Issues Voluntary Nationwide Recall of SyrSpend SF Cherry

    FDA

    Fagron Issues Voluntary Nationwide Recall of SyrSpend SF Cherry

    PRNEWSWIRE

    Fagron reports 16% increase in revenue to $156.4 million

    GLOBENEWSWIRE

    Fagron publishes agenda 2022 annual and extraordinary general meeting

    GLOBENEWSWIRE

    Fagron to present medium-term strategic objectives at its Capital Markets Day

    GLOBENEWSWIRE

    Disclosure of received notification of Kabouter Management LLC

    GLOBENEWSWIRE

    Pharma Nobis Acquires Fagron’s Contract Manufacturing Business and Facility

    BUSINESSWIRE

    Fagron strengthens position in US with acquisition of Letco

    GLOBENEWSWIRE

    Changes to Fagron’s Board of Directors

    PRESS RELEASE

    Enforcement Report - Week of December 11, 2019

    FDA

    Fagron to pay $22.5 million to settle U.S. allegations over inflated drug prices

    REUTERS

    Fagron Inc. Issues Voluntary Nationwide Recall of LETS GEL KIT Convenience Packs

    FDA

    Enforcement Report - Week of July 11, 2018

    FDA

    Fagron Sterile Services Issues Voluntary Recall of Neostigmine Methylsulfate Due to Mislabeling

    FDA

    Fagron Issues Voluntary Nationwide Recall of Neostigmine Methylsulfate

    FDA

    Enforcement Report - Week of March 7, 2018

    FDA

    Fagron,Extends Pharma Ingredient Supply Chain To American Pharma Ingredients`

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.